RPN2 and colorectal cancer: Integrated transcriptional profiling and genomic analyses reveal that ribophorin II is a promising biomarker in colorectal cancer (Zhang et al., 2015) and promotes colorectal cancer proliferation via regulating the glycosylation status of EGFR (Li et al., 2017).